Stroke Prevention by ORal Thrombin Inhibition IV "SPORTIF IV"

Completed

Phase N/A Results N/A

Summary of Purpose

To compare the safety and efficacy of ximelagatran with those of warfarin in preventing ischemic stroke in patients with non-valvular atrial fibrillation (NVAF).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 September 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

An open-label continuation of SPORTIF II, a 12-week, randomized, dose-finding study.

Contacts

Not available